PA
VCYT icon

Pinnacle Associates’s Veracyte VCYT Stock Holding History

Pinnacle Associates’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.23M Sell
106,130
-1,639
-2% -$68.7K 0.07% 245
2026
Q1 		$3.47M Buy
107,769
+55,159
+105% +$2.04M 0.04% 315
2025
Q4 		$2.21M Sell
52,610
-542
-1% -$21.8K 0.03% 384
2025
Q3 		$1.82M Sell
53,152
-1,184
-2% -$34K 0.02% 401
2025
Q2 		$1.47M Buy
54,336
+230
+0.4% +$6.66K 0.02% 435
2025
Q1 		$1.6M Buy
+54,106
New +$2.06M 0.02% 407

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Pinnacle Associates's VCYT Position: Q2 2026 in Review

Pinnacle Associates reduced its Veracyte (VCYT) stake by 1.5% in Q2 2026, selling an estimated $68.7K and leaving 106,130 shares worth $6.23M. The position accounts for 0.07% of the portfolio, ranked #245.

Pinnacle Associates first reported a position in VCYT in Q1 2025 and has held it in 6 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Pinnacle Associates held 106,130 shares of Veracyte worth $6.23M as of Q2 2026.
  • Pinnacle Associates sold 1,639 Veracyte shares in Q2 2026, an estimated $68.7K.
  • Veracyte made up 0.07% of Pinnacle Associates's portfolio in Q2 2026, its #245 holding.
  • Pinnacle Associates first reported a position in Veracyte in Q1 2025 and has held it in 6 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.